Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
J Crohns Colitis ; 12(7): 860-869, 2018 Jun 28.
Article in English | MEDLINE | ID: mdl-29547907

ABSTRACT

BACKGROUND AND AIMS: Commercial superoxide dismutase [SOD] is derived from melon extract and has a potential as a dietary supplement due to its beneficial antioxidative effects. We aimed to improve the productivity of SOD compared with plant SOD by using a generally regarded as safe [GRAS] microorganism, Bacillus amyloliquefaciens, and assess its antioxidative effect using γ-radiation- and dextransulphate sodium [DSS]-induced oxidative models in mice. METHODS: We identified the sodA gene encoding manganese-containing SODs [Mn-SOD] in B. amyloliquefaciens, constructed a Mn-SOD deficient mutant, and screened a high-SOD-producing strain. We compared the antioxidative effect of orally administered enteric-coated SOD protein partially purified from B. amyloliquefaciens with wild-type and high-SOD-producing strain spores. The effect of SOD on DSS-induced colitis was also investigated. Colonic inflammation was assessed using disease activity index, macroscopic and histological damage scores, antioxidant enzyme activities, and inflammatory cytokines. RESULTS: The SOD activity of B. amyloliquefaciens is derived from secreted Mn-SOD encoded by the sodA gene, as shown by comparing sodA knock-out mutant spores with wild-type and high-SOD-producing spores. Enteric-coated SOD of B. amyloliquefaciens appears to be effective in reducing oxidative stress in γ-radiation- and DSS-induced mouse models. Co-administration of SOD with wild-type B. amyloliquefaciens or high-SOD-producer strain spores showed a synergistic effect. SOD enzyme and B. amyloliquefaciens spores contribute to the reduction of oxidative stress and inflammatory response in DSS-induced colitis. CONCLUSIONS: Mn-SOD of B. amyloliquefaciens could be another source of SOD supplement and may be useful to prevent and treat ulcerative colitis.


Subject(s)
Bacillus amyloliquefaciens/metabolism , Colitis, Ulcerative/drug therapy , Free Radical Scavengers/pharmacology , Oxidative Stress/drug effects , Superoxide Dismutase/pharmacology , Adaptor Proteins, Signal Transducing , Animals , Bacillus amyloliquefaciens/genetics , Bacterial Proteins/genetics , Catalase/blood , Colitis, Ulcerative/blood , Colitis, Ulcerative/chemically induced , Colitis, Ulcerative/pathology , Cucurbitaceae/metabolism , Dextran Sulfate , Dietary Supplements , Female , Free Radical Scavengers/therapeutic use , Gamma Rays/adverse effects , Glutathione Peroxidase/blood , Interleukin-1beta/blood , Interleukin-6/blood , Intracellular Signaling Peptides and Proteins , Mice , Oxidative Stress/radiation effects , Proteins/metabolism , Superoxide Dismutase/biosynthesis , Superoxide Dismutase/genetics , Superoxide Dismutase/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL